How to Present a Digital Health Product Roadmap

Digital health product roadmaps are unusually hard to communicate because your audience has unusually divergent needs. A CIO wants a technology integration timeline. A CMO wants clinical evidence for each feature before it touches patients. An engineering team wants clear priorities and freedom from scope creep. A health system customer wants to know when the feature they've been waiting for actually ships. An investor wants to see a coherent narrative that validates their thesis.

A roadmap presentation that doesn't account for these divergent needs either confuses everyone or pleases no one. The right approach is a modular roadmap with audience-specific views built on a single underlying strategy.

Why Digital Health Roadmaps Are Different

Regulatory dependencies shape what can ship and when. If a feature adds diagnostic functionality, it may require FDA 510(k) clearance before release. If it creates a new PHI data flow, it needs security review and potentially BAA amendments with integration partners. These are hard constraints, not estimates.

Clinical validation gates adoption. Health systems don't turn on new digital health features for patients just because they're technically available. They wait for clinical review, IT security assessment, workflow integration, and often a pilot with outcomes monitoring. Your roadmap timeline needs to account for customer implementation cycles, not just feature release dates.

HIPAA and data governance affect every feature decision. Adding a new data element, a new integration partner, or a new user role all have data governance implications. Features that seem technically simple often have compliance complexity.

Interoperability is a major delivery risk. HL7 FHIR, EHR integrations, and payer data exchanges are critical infrastructure for most digital health products — and they're unreliable partners with varying API quality and documentation.

Slide Structure by Audience

Internal Team Roadmap Presentation

Audience: Product, engineering, clinical, and operations team.

Goal: Align on priorities, surface dependencies and risks, and create shared ownership of the plan.

Slide 1 — Strategic Context Where does the roadmap fit in the company's current phase? What major milestones (clinical study completion, regulatory filing, contract renewals, funding milestones) is the roadmap building toward?

Slide 2 — Now / Next / Later Framework Avoid commitment to specific dates beyond the nearest quarter. Use a three-horizon framework:

• Now: Actively in development; committed deliverables for the current quarter
• Next: Planned for the following quarter; subject to capacity and dependency resolution
• Later: On the backlog but not scheduled; directionally correct, details subject to change

For each item, include: owner, estimated effort, key dependencies, and success metric.

Slide 3 — Key Dependencies Map What has to happen before what? For digital health, this often includes: regulatory submissions, integration partner timelines, clinical validation data, customer implementation sequencing. A simple visual dependency map (Gantt-style or network diagram) surfaces blockers early.

Slide 4 — Clinical Validation Status For each product area, what is the evidence status?

• In use without formal study (acceptable for operational tools, not for clinical decision support)
• Retrospective analysis completed
• Prospective study in progress (dates, enrollment status)
• Published peer-reviewed evidence

This matters for the internal team because clinical validation timelines directly affect what features can be promoted externally.

Slide 5 — Regulatory Status by Feature Which features are:

• Exempt from FDA oversight
• Software as a Medical Device (SaMD) requiring FDA clearance or approval
• Currently under review
• Cleared/approved and in active use

Slide 6 — Risks and Mitigation Top three to five risks to roadmap execution:

• Integration dependency with [EHR partner] uncertain beyond Q3
• Regulatory submission for [feature] timeline depends on third-party audit completion
• Clinical study enrollment behind plan — affects claims in Q4 communications

Surface risks early and openly. A team that doesn't discuss risks doesn't mitigate them.

---

Health System Customer Roadmap Presentation

Audience: CIO, CMO, CMIO, implementation team at a key customer.

Goal: Build confidence that you're investing in the product, demonstrate that their feedback is reflected in the plan, and set accurate expectations for when they'll see specific capabilities.

Slide 1 — Our Commitment to You Acknowledge the customer's investment in your product. Brief summary of what's been delivered over the last 12 months that specifically benefited them.

Slide 2 — What We Heard Summarize the feedback you've received from this customer (and customer cohort) and how it's shaped the roadmap. This is powerful: it demonstrates that you listen and that the roadmap isn't arbitrary.

Slide 3 — Roadmap by Quarter (Current Year) Feature-level roadmap for the current year, organized by quarter. For each feature:

• Brief description
• The problem it solves
• Expected availability (quarter, not specific dates)

Be appropriately hedged: "targeted for Q3" rather than "shipping July 15th." Health system customers understand development uncertainty; what they don't accept is a precise date that slips.

Slide 4 — Looking Ahead: Following Year Direction High-level themes and major capabilities planned beyond the current year. Don't commit to specific features at specific dates beyond 12 months — but customers need to know the product is going somewhere meaningful.

Slide 5 — What We Need From You Roadmap communication should be a two-way conversation. What are the top decisions or inputs the customer needs to provide that affect their implementation or expansion plans?

• Reference site agreement for upcoming clinical study
• Decision on expanded user license for new clinical department
• Feedback on beta feature pilot

Slide 6 — Your Implementation Timeline Specific to this customer: what's deploying in their environment and when. Integration milestones, training schedules, go-live dates for pending features.

---

Investor Roadmap Presentation

Audience: Existing investors in a board update, or prospective investors in a fundraise.

Goal: Demonstrate disciplined prioritization, progress against milestones, and a credible path to the next value inflection point.

Slide 1 — Progress Since Last Update What shipped. What milestones hit. Revenue or ARR growth. Key customer wins.

Slide 2 — Current Quarter Priorities Three to five things you're shipping this quarter and why they matter.

Slide 3 — Next 12-Month Roadmap Organized by strategic theme, not feature list. Examples:

• Clinical evidence expansion: Completing the prospective study; submitting for publication; using data for enterprise sales
• EHR integration depth: Expanding FHIR integration to three additional EHR systems
• New care settings: Expanding from acute care into ambulatory and post-acute

Slide 4 — Key Milestones and Value Inflection Points What are the three to five milestones that most affect the company's valuation and market position? Timeline for each, and what specifically changes when they're reached.

---

Design and Navigation Notes

A roadmap presentation benefits from a clean visual timeline structure. Build it in slide-deck.io using a Gantt-style layout or horizon map for the visual roadmap slides, and a clean table or card layout for the feature detail. Export audience-specific versions as separate PDFs — customers shouldn't see the investor version, and investors don't need the implementation detail.

Update the deck at minimum quarterly. A roadmap that hasn't been touched in six months is not a roadmap — it's wishful thinking that has aged into fiction.